Correction: Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy

Lignende værker

• Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
  af: Restelli, Umberto, et al.
  Udgivet: (2017)
• Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy
  af: Badalamenti, Giuseppe, et al.
  Udgivet: (2019)
• Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in China
  af: Zong, Xianglong, et al.
  Udgivet: (2016)
• NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
  af: Cawston, Helene, et al.
  Udgivet: (2017)
• Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)
  af: Lorusso, Vito, et al.
  Udgivet: (2020)